- Australian Dollar: AAA rating intact but growth risks linger – BNY
- Analyst Who Accurately Called 2024 XRP Price Rally Drops Fresh Prediction
- Altcoin Open Interest Drops 15% as Bitcoin Dominance Deepens
- Annexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients
- Rezolve Ai publishes update to financial calendar
- LENSAR to report Q2 2026 results, host conference call
- Corbus Q2 FY26 net loss widens to $35.04 million; loss per share increases to $1.81
- Twin Vee Q2 FY26 net loss widens 75% to $2.9 million; net sales drop 34% to $3.13 million
- Prime Medicine Q2 FY26 net loss narrows to $42.1 million
- NextTrip partners with KC Global Media to expand JOURNY TV across Asia-Pacific, Middle East and Africa
- Latham Group CEO, CFO to join Barclays Building & Building Products Conference Q&A session
- Zscaler schedules fiscal Q4 2026 earnings call
- Koppers Q2 FY26 turns to loss of $147.5 million; net sales rise 3% to $520.1 million
- Bitcoin AI Security Audit Files 4,962 Findings Across 390 Projects
- U.S. Treasury bonds declined; earlier, British media reported that Federal Reserve Chair Waller may prepare for a rate hike in September if inflation remains strong. In addition, Alphabet (GOOG.US) launched a ten-part U.S. dollar investment-grade bond issuance.
- Alphabet (GOOG.US) launches 10-tranche US dollar investment grade bond issuance.
- Novavax 2Q Loss/Shr 32c >NVAX
- Amphenol Announces Two-for-One Stock Split And Third Quarter 2026 Dividend >APH
- Globalstar 2Q Rev $64.8M >GSAT
- Corbus Pharmaceuticals 2Q Loss/Shr $1.81 >CRBP
- Marcus & Millichap 2Q Net $3.91M >MMI
- Marcus & Millichap 2Q Rev $202.9M >MMI
- Novavax 2Q Loss $53.4M >NVAX
- Novavax 2Q Rev $56.7M >NVAX
- Fox Corp. 4Q Rev $4.21B >FOXA
- Fox Corp. 4Q EPS $1.61 >FOXA
- Fox Corp. 4Q Television Revenue $2.48B >FOXA
- Fox Corp. 4Q Cable Network Programming Revenue $1.67B >FOXA
- Tejon Ranch 2Q Rev $14.3M >TRC
- Helix Energy Solutions 2Q EPS 15c >HLX
- Helix Energy Solutions 2Q Net $22.7M >HLX
- NetApp Acquires JetStream Software To Advance Cyber Resilience And Data Protection For The AI Era >NTAP
- BioVie posts corporate presentation outlining bezisterim and BIV201 clinical programs
- Sabre posts Q2 2026 earnings release, presentation on investor relations website
- PHILLIPS 66 : RAYMOND JAMES RAISES TARGET PRICE TO $240 FROM $235
- AMGEN INC : BERNSTEIN RAISES TARGET PRICE TO $345 FROM $335
- PAR PACIFIC HOLDINGS INC : RAYMOND JAMES RAISES TARGET PRICE TO $90 FROM $85
- Karooooo CEO, Executive Chairman IJ Calisto disposes of USD 3.89 million in common shares
- InflaRx posts H1 loss as warrant fair-value hit outweighs FX gains, R&D spending falls
- SSR MINING INC. <SSRM.TO>: NATIONAL BANK OF CANADA RAISES TARGET PRICE TO C$67 FROM C$57
- The US dollar against the Swiss franc has just reached the 0.8100 mark, now quoted at 0.8100, up 0.37% for the day.
- JANUS LIVING INC <JAN.N>: RAYMOND JAMES RAISES TARGET PRICE TO $40 FROM $34
- BRIEF-Sempra Q2 Adjusted EPS USD 1.16 Vs. IBES Estimate USD 1.06
- BRIEF-Koppers Q2 Adjusted EPS USD 1.37 Vs. IBES Estimate USD 1.12
- SANDISK CORPORATION <SNDK.O>: SUSQUEHANNA CUTS TARGET PRICE TO $2745 FROM $3050
- Koppers 2Q Adj EPS $1.37 >KOP
- Koppers 2Q Loss/Shr $7.71 >KOP
- Koppers 2Q Sales $520.1M >KOP
- Sempra Sees FY EPS $5.02-EPS $5.55 >SRE
- Sempra Sees FY Adj EPS $4.80-Adj EPS $5.30 >SRE
- NEAR Targets $1.85 as Sovereign Fund Proposal Lifts Bullish Momentum
- Oroco drills 26.48 m at 1.18% CuEq in Santo Tomas South Zone, Mexico
- Novavax Q2 FY26 turns to net loss of $53.39 million; revenue drops 76.29% to $56.7 million
- Agenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer
- argenx launches tender offer for Forte Biosciences at $77 a share
- AI Demand Remains Strong: UMC (UMC.US) July Revenue Surges by 19%, Confirming the Expansion of Computing Power Chains to Mature Processes
- AI demand remains strong: UMC’s July revenue surged 19%, verifying the spread of computing power chains to mature process nodes
- Spot gold has just surpassed the $4,260.00/ounce mark, now quoted at $4,259.74/ounce, up 0.30% on the day; COMEX gold futures main contract is now quoted at $4,319.00/ounce, up 0.32% on the day.
- Paramount (PSKY.US): The transaction does not raise any antitrust concerns in any market.
- Paramount (PSKY.US): The UK Competition and Markets Authority (CMA) has approved Paramount Skydance's acquisition of Warner Bros.
- WYNN RESORTS, LIMITED <WYNN.O>: ARGUS RESEARCH RAISES TARGET PRICE TO $130 FROM $115
- INSULET CORPORATION : RAYMOND JAMES CUTS TARGET PRICE TO $180 FROM $216
- Cresco Labs cites Pennsylvania dispensary acquisitions, Ohio adult-use lift as Q2 2026 revenue rises 5.9%
- IDEX CORPORATION <IEX.N>: ARGUS RESEARCH RAISES TARGET PRICE TO $260 FROM $250
- Iochpe-Maxion publishes 2Q26 earnings presentation
- Cheniere Energy Partners Q2 net income more than doubles on higher LNG volumes
- Frasle Mobility controlling shareholder trims stake by R$ 196,198 via net share sales and buys
- BLOCK, INC. <XYZ.N>: RAYMOND JAMES RAISES TARGET PRICE TO $97 FROM $90
- ADVANCED MICRO DEVICES : ARGUS RESEARCH RAISES TARGET PRICE TO $625 FROM $450
- BRISTOW GROUP INC. <VTOL.N>: RAYMOND JAMES RAISES TARGET PRICE TO $67 FROM $60
- AVNET INC : RAYMOND JAMES RAISES TARGET PRICE TO $120 FROM $95
- Charter upsizes debt exchange offers, raises new secured notes caps to USD 2 billion each
- Cairo Communication says H1 2026 half-year financial statement is filed
- ROPER TECHNOLOGIES, INC. <ROP.O>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- Helleniq Energy releases transcript of Q2 and H1 2026 results call
- Yellow Pages 2Q EPS C$0.24 >Y.T
- Yellow Pages 2Q Rev C$47.6M >Y.T
- NetScout Systems Backs FY27 Adj EPS $2.80 >NTCT
- Lexicon Pharma: NDA Resubmission Activities for ZYNQUISTA in Type 1 Diabetes Nearing Completion >LXRX
- NetScout Systems Backs FY27 EPS $1.55-EPS $1.70 >NTCT
- NetScout Systems Reaffirms Full-Yr Outlook >NTCT
- NetScout Systems Backs FY27 Rev $885M-$915M >NTCT
- Kelly Services Sees Low-To-Mid Single Digit Total Rev Decline for FY26 >KELYA
- HUBSPOT, INC. <HUBS.N>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $200.00 FROM $210.00
- ENCOMPASS HEALTH <EHC.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $153.00 FROM $150.00
- DOORDASH <DASH.O>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $275.00 FROM $272.00
- Deep Isolation net loss widens to $3.04 million in Q2 FY26; revenue falls 19% to $1.32 million
- Kelly Services Sees 3Q Total Rev to Be Flat to Decline of 2% Versus Prior Yr >KELYA
- KKR REAL ESTATE FINANCE TRUST INC <KREF.N>: RAYMOND JAMES RAISES TO STRONG BUY FROM MARKET PERFORM
- ADVANCED MICRO DEVICES : ROSENBLATT SECURITIES RAISES TARGET PRICE TO $700 FROM $665
- Kelly Services Affirms Adj EBITDA Margin Expectation of Modest Yr-over-Yr Growth >KELYA
- Ingles Markets 3Q Net $25.9M >IMKTA
- Ingles Markets 3Q Sales $1.37B >IMKTA
- Cheniere Energy 2Q EPS $14.65 >LNG
- Cheniere Energy 2Q Rev $5.73B >LNG
- MACOM Technology 3Q EPS $1.28 >MTSI
- Becton Dickinson 3Q Net $377M >BDX
- Becton Dickinson 3Q EPS $1.37 >BDX
- Becton Dickinson 3Q Rev $4.98B >BDX
- Becton Dickinson Sees FY Adj EPS $12.62-Adj EPS $12.72 >BDX
